Elutia (ELUT) Submits CanGarooRM Antibiotic-Eluting Biomatrix for FDA Clearance Dec 18, 2023 08:06AM
Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance Dec 18, 2023 08:00AM
Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results Nov 13, 2023 04:05PM
Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million Nov 9, 2023 08:30AM
Elutia (ELUT) Announces Private Placement for Proceeds Up to $26 Million Sep 19, 2023 08:37AM


Sep 19, 2023 08:36AM Elutia Announces Private Placement for Proceeds Up to $26 Million
Sep 18, 2023 04:09PM Elutia (ELUT) Sells Orthobiologics Business Unit for Up to $35M Cash
Sep 18, 2023 04:08PM Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
Sep 6, 2023 04:09PM Aziyo Biologics (AZYO) Rebrands as Elutia, Changes Ticker to ELUT
Sep 6, 2023 04:05PM Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices